Skandinaviska Enskilda Banken (SEB)’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,000
Closed -$375K 932
2023
Q4
$375K Hold
12,000
﹤0.01% 795
2023
Q3
$482K Sell
12,000
-2,400
-17% -$112K ﹤0.01% 770
2023
Q2
$757K Sell
14,400
-4,500
-24% -$274K 0.01% 738
2023
Q1
$1.21M Buy
+18,900
New +$1.23M 0.01% 665
2022
Q3
Sell
-10,607
Closed -$752K 1018
2022
Q2
$752K Buy
10,607
+6,830
+181% +$440K 0.01% 751
2022
Q1
$302K Sell
3,777
-1,878
-33% -$140K ﹤0.01% 867
2021
Q4
$530K Hold
5,655
﹤0.01% 840
2021
Q3
$727K Sell
5,655
-12,067
-68% -$1.69M ﹤0.01% 835
2021
Q2
$2.7M Buy
17,722
+501
+3% +$66K 0.02% 586
2021
Q1
$1.81M Sell
17,221
-1,939
-10% -$194K 0.01% 690
2020
Q4
$1.52M Sell
19,160
-6,383
-25% -$467K 0.01% 726
2020
Q3
$1.45M Buy
25,543
+24,967
+4,335% +$1.34M 0.01% 660
2020
Q2
$35K Buy
+576
New +$23.5K ﹤0.01% 1004

Other funds holding STAA

Skandinaviska Enskilda Banken (SEB)'s STAA Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of STAAR Surgical (STAA) in Q1 2024, closing a stake of 12,000 shares — an estimated $375K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in STAA in Q2 2020 and held it in 13 quarters. The position peaked at $2.7M in Q2 2021. 198 funds tracked by Wall St. Rank hold STAA as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining STAAR Surgical position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 12,000 STAAR Surgical shares in Q1 2024, an estimated $375K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in STAAR Surgical in Q2 2020 and held it in 13 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s STAAR Surgical position peaked at $2.7M in Q2 2021.
  • 198 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.